Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,552,453
+$823,984 QoQ
Shares Held
26,039
-1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#1,149
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DE BURLO GROUP INC holds $41,576,322 across 7 Drug Manufacturers - General names. ABBV ranks #2 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,613 | $31,920,433 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
26,039 | $6,552,453 | |
| 3 | AZN |
Astrazeneca PLC
|
5,753 | $1,090,883 | |
| 4 | NVO |
Novo Nordisk A S
|
15,250 | $731,085 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,758 | $727,465 | |
| 6 | JNJ |
Johnson & Johnson
|
1,333 | $338,542 | |
| 7 | AMGN |
Amgen Inc
|
595 | $215,461 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,552,453 | 26,039 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,728,469 | 26,339 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,075,320 | 26,589 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,237,456 | 26,939 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,988,908 | 26,877 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,787,151 | 27,621 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,961,561 | 27,921 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,954,219 | 30,151 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,343,019 | 31,151 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,852,876 | 32,141 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $5,147,483 | 33,216 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,951,176 | 33,216 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $4,502,137 | 33,416 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,309,570 | 33,316 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,432,681 | 33,616 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,592,129 | 34,216 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,751,844 | 11,438 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,579,177 | 34,416 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,768,246 | 35,216 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $3,698,107 | 34,283 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $3,857,920 | 34,250 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,706,535 | 34,250 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $3,680,602 | 34,350 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $2,798,500 | 31,950 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $12,989,214 | 132,300 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $10,079,937 | 132,300 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||